| 期刊論文1. | Glacken, M., Coates, V., Kernohan, G.,、Hegarty, J.(2003)。The experience of fatigue for people living with hepatitis C。Journal of Clinical Nursing,12(2),244-253。 | 2. | 李燕鳴(20040200)。基層醫療中C型肝炎之諮詢與防制。基層醫學,19(2),41-46。 延伸查詢 | 3. | 許景盛、高嘉宏(20070900)。病毒性肝炎與代謝症候群。臺灣醫學,11(5),518-529。 延伸查詢 | 4. | 曾光毅、曾嵩智、林佩璇(20040300)。現階段C型肝炎的預防與治療。基層醫學,19(3),61-66。 延伸查詢 | 5. | 李昱、楊明仁、賴德仁、邱念睦、周騰達(20001100)。Development of the Taiwanese Depression Questionnaire。長庚醫學,23(11),688-694。 延伸查詢 | 6. | 林聰蓉、廖麗瑛、王鐘貴(2007)。慢性C型肝炎治療的新展望。北市醫學雜誌,4(9),873-879。 延伸查詢 | 7. | 張淑娟、楊勝舜(2006)。慢性C型肝炎患者接受干擾素合併Ribavirin治療的生活經驗。實證護理,2(1),34-42。 延伸查詢 | 8. | 莊萬龍、余明隆(2007)。慢性C型肝炎之治療。台灣醫學,11(5),507-517。 延伸查詢 | 9. | Bonkovsky, H. L., Snow, K. K., Malet, P. F., Back-Madruga, C.,Fontana, R. J., Sterling, R. K., et al.(2007)。Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis。Journal of Hepatology,46(3),420-431。 | 10. | Chang, S. C., Ko, W. S., Wu, S. S., Peng, C. Y.,、Yang, S. S.(2008)。Factors associated with quality of life in chronic hepatitis C patients who received interferon plus ribavirin therapy。Journal of Formosan Medical Association,107(6),454-462。 | 11. | Iosue, K.(2002)。Chronic hepatitis C: Latest treatment options。The Nurse Practitioner,27(4),32-49。 | 12. | Lieb, K., Engelbrecht, M. A., Gut, O., Feibich, B. L., Bauer, J.,Janssen, G., et al.(2006)。Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα):Results from a prospective study。European Psychiatry,21(3),204-210。 | 13. | Sherman, M., Cohen, L., Cooper, M. A., Elkashab, M., Feinman,V., Fletcher, D., et al.(2006)。Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin。Canadian Journal of Gastroenteroloy,20(8),519-520。 | 14. | Strader, D. B., Wright, T., Thomas, D. L.,、Seeff, L. B.(2004)。Diagnosis, management, and treatment of hepatitis C。Hepatology,39(4),1147-1171。 | 15. | Sulkowski, M. S.(2005)。Management of the hematologic complications of hepatitis C therapy。Hepatology,9(4),601-616。 | 16. | The Global Burden of Hepatitis C Working Group.(2004)。Global burden of disease (GBD) for hepatitis C。Journal of Clinical Pharmacology,44(1),20-29。 | 17. | Dan, A. A., Martin, L. M., Crone, C., Ong, J. P., Farmer, D. W., Wise, T., et al.(2006)。Depression, anemia and health related quality of life in chronic hepatitis C。Journal of Hepatology,44(3),491-498。 | 18. | Ferenci, P., Formann, E., Laferl, H., Gschwantler, M., Hackl, F., Brunner, H., et al.(2006)。Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naive patients with chronic hepatitis C genotype 1 infection。Journal of Hepatology,44(2),275-285。 | 圖書1. | 姚開屏(2005)。台灣簡明版世界衛生組織生活品質問卷之發展及使用手冊。台北:世界衛生組織生活品質問卷台灣簡明版發展小組。 延伸查詢 | |